The investigation of the survival time after recurrence in patients with pancreatic ductal adenocarcinoma for individualization of adjuvant chemotherapy-Reference-Cited by-同舟云学术

The investigation of the survival time after recurrence in patients with pancreatic ductal adenocarcinoma for individualization of adjuvant chemotherapy

Published:2018-05-17 Issue:10 Volume:48 Page:952-962
ISSN:0941-1291
Container-title:Surgery Today
language:en
Short-container-title:Surg Today

Author:

Yamada Daisaku,Eguchi Hidetoshi,Iwagami Yoshifumi,Asaoka Tadafumi,Noda Takehiro,Kawamoto Koichi,Gotoh Kunihito,Kobayashi Shogo,Mori Masaki,Doki Yuichiro

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Surgery

Link

http://link.springer.com/article/10.1007/s00595-018-1674-3/fulltext.html

Reference39 articles.

1. Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet. 2011;378(9791):607–20.

2. Mikamori M, Yamada D, Eguchi H, Hasegawa S, Kishimoto T, Tomimaru Y, et al. MicroRNA-155 controls exosome synthesis and promotes gemcitabine resistance in pancreatic ductal adenocarcinoma. Sci Rep. 2017;7:42339.

3. Mizuguchi T, Torigoe T, Satomi F, Shima H, Kutomi G, Ota S, et al. Trials of vaccines for pancreatic ductal adenocarcinoma: Is there any hope of an improved prognosis? Surg Today. 2016;46(2):139–48.

4. Asari S, Matsumoto I, Toyama H, Shinzeki M, Goto T, Ishida J, et al. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios. Surg Today. 2016;46(5):583–92.

5. Komo T, Murakami Y, Kondo N, Uemura K, Hashimoto Y, Nakagawa N, et al. Prognostic impact of para-aortic lymph node micrometastasis in pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2016;23(6):2019–27.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Organ-specific variations in tumor marker dynamics in postoperative pancreatic cancer recurrence: Trends in lung and liver recurrence highlighting biological heterogeneity;Surgical Oncology;2024-08

2. Efficacy of local treatment for isolated liver metastasis after pancreatectomy in pancreatic ductal adenocarcinoma: A propensity score‐matched analysis;Journal of Hepato-Biliary-Pancreatic Sciences;2023-10-06

3. Predicting post-recurrence survival for patients with pancreatic cancer recurrence after primary resection: A Bi-institutional validated risk classification;European Journal of Surgical Oncology;2023-09

4. Change Impact of Body Composition During Neoadjuvant Chemoradiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Pancreatectomy;Annals of Surgical Oncology;2022-12-27

5. Investigation of Conversion Surgery for Initial UR-PDAC: Is Adjuvant Chemotherapy Still Necessary?;The Japanese Journal of Gastroenterological Surgery;2021-10-01